Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Adults with hypophosphatasia (HPP) typically have a normal or near-normal life expectancy, but untreated complications like recurrent metatarsal stress fractures, femoral pseudofractures, chronic bone and muscle pain, early tooth loss, and pyrophosphate arthropathy can drive progressive disability, mobility loss, and opioid dependence. Coordinated care across endocrinology, orthopedics, rheumatology, dentistry, physical therapy, pain management, and genetic counseling is what shifts the outcome, because low alkaline phosphatase (ALP) plus ALPL genetic confirmation opens the door to enzyme replacement therapy and prevents harmful missteps such as bisphosphonates or high-dose vitamin D. Several factors influence long-term function, including age at diagnosis, fracture history, and whether care is fragmented or truly integrated, so see below to understand the details that matter most.
If you have unexplained fractures, persistent bone or joint pain, unusual fatigue, or adult tooth loss, mapping your symptoms clearly is the fastest first step toward the right specialist and away from years of misdiagnosis. Take a free, instant, online symptom check to better understand what may be driving your symptoms and what to do next.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia (HPP) is a rare genetic disorder characterized by low activity of the enzyme alkaline phosphatase. In adults, HPP can present with stress fractures, bone pain, dental issues and muscle weakness. With a growing number of diagnoses in adulthood, questions often arise about “Hypophosphatasia life expectancy adult diagnosis.” While HPP varies widely in severity, most adults diagnosed with the milder forms can expect a normal life span. However, chronic complications can impact quality of life if left unmanaged.
Adult HPP often emerges with subtle signs, leading to delays in diagnosis. Key points include:
Early recognition through clinical evaluation and lab work helps guide effective management, improving both function and long-term outcomes.
Data on adult life expectancy in HPP is reassuring for most patients:
Regular monitoring and proactive treatment of fractures, muscle weakness and dental issues help maintain independence and reduce long-term disability risk.
Preventing disability in adult HPP requires a coordinated team approach. Key specialists include:
Medical Management
Orthopedic Support
Rehabilitation
Dental Care
Nutrition and Lifestyle
A well-organized care team can:
By integrating these elements, adults with HPP experience fewer interruptions to daily life and maintain better long-term function.
Obtain a Confirmed Diagnosis
Assemble Your Care Team
Monitor Your Health
Stay Active Safely
Mind Your Mental Health
If you experience new or worsening symptoms—such as persistent bone pain, unexplained stress fractures, muscle weakness or dental issues—you might benefit from a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you identify potential concerns and decide when to contact your healthcare team.
Important: Always speak to a doctor if you have symptoms that could be life-threatening or seriously affect your health. Your healthcare team can tailor a management plan based on your unique needs and ensure you receive the best care possible.
(References)
* Beck C, Morbach H, Stenzel M, Schneider P, Collmann H, Girschick G, Girschick HJ. [Hypophosphatasia]. Klin Padiatr. 2009 Jul-Aug;221(4):219-26. doi: 10.1055/s-0029-1220718. Epub 2009 Jul 23. PMID: 19629901.
* Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Marini JC, Dang Do AN. Osteogenesis Imperfecta. 2000. PMID: 25905334.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A. Hypophosphatasia. J Clin Med. 2021 Dec 1;10(23). doi: 10.3390/jcm10235676. Epub 2021 Dec 1. PMID: 34884378; PMCID: PMC8658462.
* Farman MR, Rehder C, Malli T, Rockman-Greenberg C, Dahir K, Martos-Moreno GÁ, Linglart A, Ozono K, Seefried L, Del Angel G, Webersinke G, Barbazza F, John LK, Delana Mudiyanselage SMA, Högler F, Nading EB, Huggins E, Rush ET, El-Gazzar A, Kishnani PS, Högler W. The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone. 2024 Jan;178:116947. doi: 10.1016/j.bone.2023.116947. Epub 2023 Oct 26. PMID: 37898381.
* Rush E, Brandi ML, Khan A, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Starling SR, Ward L, Yao L, Brignardello-Petersen R, Simmons JH. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024 Jan;35(1):1-10. doi: 10.1007/s00198-023-06843-2. Epub 2023 Nov 20. PMID: 37982855; PMCID: PMC10786745.
* Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar;35(3):431-438. doi: 10.1007/s00198-023-06844-1. Epub 2023 Nov 20. PMID: 37982857; PMCID: PMC10866785.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.